ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clinical Biomarkers Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-13F5976
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Clinical Biomarkers Market Insights Forecast to 2028
BUY CHAPTERS

Global Clinical Biomarkers Market Research Report 2025

Code: QYRE-Auto-13F5976
Report
June 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Agilent Technologies Inc
ALCEDIAG
Becton Dickinson and Company
bioMérieux
Bio-Rad Laboratories Inc
CENTOGENE N.V
F Hoffmann La Roche Ltd
Enzo Biochem, Inc.
Illumina Inc
Myriad Genetics Inc
Quest Diagnostics Incorporated
QIAGEN N V
Thermo Fisher Scientific Inc

Clinical Biomarkers Market

The global market for Clinical Biomarkers was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Biomarkers are a class of markers related to cell growth and proliferation that have been proposed in recent years with the development of immunology and molecular biology techniques. Biomarkers can not only discuss the pathogenesis at the molecular level, but also have a unique advantage in accurately and sensitively evaluating early and low-level damage. They can provide early warning, which largely provides clinicians with auxiliary diagnosis Basis.
North American market for Clinical Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Clinical Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Clinical Biomarkers in Research and Academic Laboratories is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Clinical Biomarkers include Abbott Laboratories, Agilent Technologies, Inc., ALCEDIAG, Becton, Dickinson and Company, bioMérieux S.A., Bio-Rad Laboratories, Inc., CENTOGENE N.V., F. Hoffmann-La Roche Ltd., Enzo Biochem Inc., Illumina, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Biomarkers.
The Clinical Biomarkers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Clinical Biomarkers Market Report

Report Metric Details
Report Name Clinical Biomarkers Market
Segment by Type
  • Diagnostic Biomarkers
  • Predictive Biomarkers
  • Prognostic Biomarkers
Segment by Application
  • Research and Academic Laboratories
  • Biopharmaceutical and Biotech Companies
  • Diagnostic Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Agilent Technologies, Inc., ALCEDIAG, Becton, Dickinson and Company, bioMérieux S.A., Bio-Rad Laboratories, Inc., CENTOGENE N.V., F. Hoffmann-La Roche Ltd., Enzo Biochem Inc., Illumina, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, QIAGEN N.V., Thermo Fisher Scientific Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Clinical Biomarkers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Clinical Biomarkers Market report?

Ans: The main players in the Clinical Biomarkers Market are Abbott Laboratories, Agilent Technologies, Inc., ALCEDIAG, Becton, Dickinson and Company, bioMérieux S.A., Bio-Rad Laboratories, Inc., CENTOGENE N.V., F. Hoffmann-La Roche Ltd., Enzo Biochem Inc., Illumina, Inc., Myriad Genetics, Inc., Quest Diagnostics Incorporated, QIAGEN N.V., Thermo Fisher Scientific Inc.

What are the Application segmentation covered in the Clinical Biomarkers Market report?

Ans: The Applications covered in the Clinical Biomarkers Market report are Research and Academic Laboratories, Biopharmaceutical and Biotech Companies, Diagnostic Centers, Others

What are the Type segmentation covered in the Clinical Biomarkers Market report?

Ans: The Types covered in the Clinical Biomarkers Market report are Diagnostic Biomarkers, Predictive Biomarkers, Prognostic Biomarkers

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarkers Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diagnostic Biomarkers
1.2.3 Predictive Biomarkers
1.2.4 Prognostic Biomarkers
1.3 Market by Application
1.3.1 Global Clinical Biomarkers Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research and Academic Laboratories
1.3.3 Biopharmaceutical and Biotech Companies
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarkers Market Perspective (2020-2031)
2.2 Global Clinical Biomarkers Growth Trends by Region
2.2.1 Global Clinical Biomarkers Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Biomarkers Historic Market Size by Region (2020-2025)
2.2.3 Clinical Biomarkers Forecasted Market Size by Region (2026-2031)
2.3 Clinical Biomarkers Market Dynamics
2.3.1 Clinical Biomarkers Industry Trends
2.3.2 Clinical Biomarkers Market Drivers
2.3.3 Clinical Biomarkers Market Challenges
2.3.4 Clinical Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarkers Players by Revenue
3.1.1 Global Top Clinical Biomarkers Players by Revenue (2020-2025)
3.1.2 Global Clinical Biomarkers Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Biomarkers Revenue
3.4 Global Clinical Biomarkers Market Concentration Ratio
3.4.1 Global Clinical Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarkers Revenue in 2024
3.5 Global Key Players of Clinical Biomarkers Head office and Area Served
3.6 Global Key Players of Clinical Biomarkers, Product and Application
3.7 Global Key Players of Clinical Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarkers Breakdown Data by Type
4.1 Global Clinical Biomarkers Historic Market Size by Type (2020-2025)
4.2 Global Clinical Biomarkers Forecasted Market Size by Type (2026-2031)
5 Clinical Biomarkers Breakdown Data by Application
5.1 Global Clinical Biomarkers Historic Market Size by Application (2020-2025)
5.2 Global Clinical Biomarkers Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Biomarkers Market Size (2020-2031)
6.2 North America Clinical Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Biomarkers Market Size by Country (2020-2025)
6.4 North America Clinical Biomarkers Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Biomarkers Market Size (2020-2031)
7.2 Europe Clinical Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Biomarkers Market Size by Country (2020-2025)
7.4 Europe Clinical Biomarkers Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarkers Market Size (2020-2031)
8.2 Asia-Pacific Clinical Biomarkers Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Biomarkers Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Biomarkers Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Biomarkers Market Size (2020-2031)
9.2 Latin America Clinical Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Biomarkers Market Size by Country (2020-2025)
9.4 Latin America Clinical Biomarkers Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarkers Market Size (2020-2031)
10.2 Middle East & Africa Clinical Biomarkers Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Biomarkers Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Biomarkers Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarkers Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarkers Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Details
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. Clinical Biomarkers Introduction
11.2.4 Agilent Technologies, Inc. Revenue in Clinical Biomarkers Business (2020-2025)
11.2.5 Agilent Technologies, Inc. Recent Development
11.3 ALCEDIAG
11.3.1 ALCEDIAG Company Details
11.3.2 ALCEDIAG Business Overview
11.3.3 ALCEDIAG Clinical Biomarkers Introduction
11.3.4 ALCEDIAG Revenue in Clinical Biomarkers Business (2020-2025)
11.3.5 ALCEDIAG Recent Development
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Company Details
11.4.2 Becton, Dickinson and Company Business Overview
11.4.3 Becton, Dickinson and Company Clinical Biomarkers Introduction
11.4.4 Becton, Dickinson and Company Revenue in Clinical Biomarkers Business (2020-2025)
11.4.5 Becton, Dickinson and Company Recent Development
11.5 bioMérieux S.A.
11.5.1 bioMérieux S.A. Company Details
11.5.2 bioMérieux S.A. Business Overview
11.5.3 bioMérieux S.A. Clinical Biomarkers Introduction
11.5.4 bioMérieux S.A. Revenue in Clinical Biomarkers Business (2020-2025)
11.5.5 bioMérieux S.A. Recent Development
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Details
11.6.2 Bio-Rad Laboratories, Inc. Business Overview
11.6.3 Bio-Rad Laboratories, Inc. Clinical Biomarkers Introduction
11.6.4 Bio-Rad Laboratories, Inc. Revenue in Clinical Biomarkers Business (2020-2025)
11.6.5 Bio-Rad Laboratories, Inc. Recent Development
11.7 CENTOGENE N.V.
11.7.1 CENTOGENE N.V. Company Details
11.7.2 CENTOGENE N.V. Business Overview
11.7.3 CENTOGENE N.V. Clinical Biomarkers Introduction
11.7.4 CENTOGENE N.V. Revenue in Clinical Biomarkers Business (2020-2025)
11.7.5 CENTOGENE N.V. Recent Development
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Details
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in Clinical Biomarkers Business (2020-2025)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
11.9 Enzo Biochem Inc.
11.9.1 Enzo Biochem Inc. Company Details
11.9.2 Enzo Biochem Inc. Business Overview
11.9.3 Enzo Biochem Inc. Clinical Biomarkers Introduction
11.9.4 Enzo Biochem Inc. Revenue in Clinical Biomarkers Business (2020-2025)
11.9.5 Enzo Biochem Inc. Recent Development
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Clinical Biomarkers Introduction
11.10.4 Illumina, Inc. Revenue in Clinical Biomarkers Business (2020-2025)
11.10.5 Illumina, Inc. Recent Development
11.11 Myriad Genetics, Inc.
11.11.1 Myriad Genetics, Inc. Company Details
11.11.2 Myriad Genetics, Inc. Business Overview
11.11.3 Myriad Genetics, Inc. Clinical Biomarkers Introduction
11.11.4 Myriad Genetics, Inc. Revenue in Clinical Biomarkers Business (2020-2025)
11.11.5 Myriad Genetics, Inc. Recent Development
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Details
11.12.2 Quest Diagnostics Incorporated Business Overview
11.12.3 Quest Diagnostics Incorporated Clinical Biomarkers Introduction
11.12.4 Quest Diagnostics Incorporated Revenue in Clinical Biomarkers Business (2020-2025)
11.12.5 Quest Diagnostics Incorporated Recent Development
11.13 QIAGEN N.V.
11.13.1 QIAGEN N.V. Company Details
11.13.2 QIAGEN N.V. Business Overview
11.13.3 QIAGEN N.V. Clinical Biomarkers Introduction
11.13.4 QIAGEN N.V. Revenue in Clinical Biomarkers Business (2020-2025)
11.13.5 QIAGEN N.V. Recent Development
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Details
11.14.2 Thermo Fisher Scientific Inc. Business Overview
11.14.3 Thermo Fisher Scientific Inc. Clinical Biomarkers Introduction
11.14.4 Thermo Fisher Scientific Inc. Revenue in Clinical Biomarkers Business (2020-2025)
11.14.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Agilent Technologies Inc
ALCEDIAG
Becton Dickinson and Company
bioMérieux
Bio-Rad Laboratories Inc
CENTOGENE N.V
F Hoffmann La Roche Ltd
Enzo Biochem, Inc.
Illumina Inc
Myriad Genetics Inc
Quest Diagnostics Incorporated
QIAGEN N V
Thermo Fisher Scientific Inc
List of Tables
 Table 1. Global Clinical Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Diagnostic Biomarkers
 Table 3. Key Players of Predictive Biomarkers
 Table 4. Key Players of Prognostic Biomarkers
 Table 5. Global Clinical Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Clinical Biomarkers Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Clinical Biomarkers Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Clinical Biomarkers Market Share by Region (2020-2025)
 Table 9. Global Clinical Biomarkers Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Clinical Biomarkers Market Share by Region (2026-2031)
 Table 11. Clinical Biomarkers Market Trends
 Table 12. Clinical Biomarkers Market Drivers
 Table 13. Clinical Biomarkers Market Challenges
 Table 14. Clinical Biomarkers Market Restraints
 Table 15. Global Clinical Biomarkers Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Clinical Biomarkers Market Share by Players (2020-2025)
 Table 17. Global Top Clinical Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarkers as of 2024)
 Table 18. Ranking of Global Top Clinical Biomarkers Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Clinical Biomarkers Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Clinical Biomarkers, Headquarters and Area Served
 Table 21. Global Key Players of Clinical Biomarkers, Product and Application
 Table 22. Global Key Players of Clinical Biomarkers, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Clinical Biomarkers Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Clinical Biomarkers Revenue Market Share by Type (2020-2025)
 Table 26. Global Clinical Biomarkers Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Clinical Biomarkers Revenue Market Share by Type (2026-2031)
 Table 28. Global Clinical Biomarkers Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Clinical Biomarkers Revenue Market Share by Application (2020-2025)
 Table 30. Global Clinical Biomarkers Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Clinical Biomarkers Revenue Market Share by Application (2026-2031)
 Table 32. North America Clinical Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Clinical Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Clinical Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Clinical Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Clinical Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Clinical Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Clinical Biomarkers Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Clinical Biomarkers Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Clinical Biomarkers Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Clinical Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Clinical Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Clinical Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Clinical Biomarkers Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Clinical Biomarkers Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Clinical Biomarkers Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Abbott Laboratories Company Details
 Table 48. Abbott Laboratories Business Overview
 Table 49. Abbott Laboratories Clinical Biomarkers Product
 Table 50. Abbott Laboratories Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 51. Abbott Laboratories Recent Development
 Table 52. Agilent Technologies, Inc. Company Details
 Table 53. Agilent Technologies, Inc. Business Overview
 Table 54. Agilent Technologies, Inc. Clinical Biomarkers Product
 Table 55. Agilent Technologies, Inc. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 56. Agilent Technologies, Inc. Recent Development
 Table 57. ALCEDIAG Company Details
 Table 58. ALCEDIAG Business Overview
 Table 59. ALCEDIAG Clinical Biomarkers Product
 Table 60. ALCEDIAG Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 61. ALCEDIAG Recent Development
 Table 62. Becton, Dickinson and Company Company Details
 Table 63. Becton, Dickinson and Company Business Overview
 Table 64. Becton, Dickinson and Company Clinical Biomarkers Product
 Table 65. Becton, Dickinson and Company Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 66. Becton, Dickinson and Company Recent Development
 Table 67. bioMérieux S.A. Company Details
 Table 68. bioMérieux S.A. Business Overview
 Table 69. bioMérieux S.A. Clinical Biomarkers Product
 Table 70. bioMérieux S.A. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 71. bioMérieux S.A. Recent Development
 Table 72. Bio-Rad Laboratories, Inc. Company Details
 Table 73. Bio-Rad Laboratories, Inc. Business Overview
 Table 74. Bio-Rad Laboratories, Inc. Clinical Biomarkers Product
 Table 75. Bio-Rad Laboratories, Inc. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 76. Bio-Rad Laboratories, Inc. Recent Development
 Table 77. CENTOGENE N.V. Company Details
 Table 78. CENTOGENE N.V. Business Overview
 Table 79. CENTOGENE N.V. Clinical Biomarkers Product
 Table 80. CENTOGENE N.V. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 81. CENTOGENE N.V. Recent Development
 Table 82. F. Hoffmann-La Roche Ltd. Company Details
 Table 83. F. Hoffmann-La Roche Ltd. Business Overview
 Table 84. F. Hoffmann-La Roche Ltd. Clinical Biomarkers Product
 Table 85. F. Hoffmann-La Roche Ltd. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 86. F. Hoffmann-La Roche Ltd. Recent Development
 Table 87. Enzo Biochem Inc. Company Details
 Table 88. Enzo Biochem Inc. Business Overview
 Table 89. Enzo Biochem Inc. Clinical Biomarkers Product
 Table 90. Enzo Biochem Inc. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 91. Enzo Biochem Inc. Recent Development
 Table 92. Illumina, Inc. Company Details
 Table 93. Illumina, Inc. Business Overview
 Table 94. Illumina, Inc. Clinical Biomarkers Product
 Table 95. Illumina, Inc. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 96. Illumina, Inc. Recent Development
 Table 97. Myriad Genetics, Inc. Company Details
 Table 98. Myriad Genetics, Inc. Business Overview
 Table 99. Myriad Genetics, Inc. Clinical Biomarkers Product
 Table 100. Myriad Genetics, Inc. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 101. Myriad Genetics, Inc. Recent Development
 Table 102. Quest Diagnostics Incorporated Company Details
 Table 103. Quest Diagnostics Incorporated Business Overview
 Table 104. Quest Diagnostics Incorporated Clinical Biomarkers Product
 Table 105. Quest Diagnostics Incorporated Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 106. Quest Diagnostics Incorporated Recent Development
 Table 107. QIAGEN N.V. Company Details
 Table 108. QIAGEN N.V. Business Overview
 Table 109. QIAGEN N.V. Clinical Biomarkers Product
 Table 110. QIAGEN N.V. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 111. QIAGEN N.V. Recent Development
 Table 112. Thermo Fisher Scientific Inc. Company Details
 Table 113. Thermo Fisher Scientific Inc. Business Overview
 Table 114. Thermo Fisher Scientific Inc. Clinical Biomarkers Product
 Table 115. Thermo Fisher Scientific Inc. Revenue in Clinical Biomarkers Business (2020-2025) & (US$ Million)
 Table 116. Thermo Fisher Scientific Inc. Recent Development
 Table 117. Research Programs/Design for This Report
 Table 118. Key Data Information from Secondary Sources
 Table 119. Key Data Information from Primary Sources
 Table 120. Authors List of This Report


List of Figures
 Figure 1. Clinical Biomarkers Picture
 Figure 2. Global Clinical Biomarkers Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Clinical Biomarkers Market Share by Type: 2024 VS 2031
 Figure 4. Diagnostic Biomarkers Features
 Figure 5. Predictive Biomarkers Features
 Figure 6. Prognostic Biomarkers Features
 Figure 7. Global Clinical Biomarkers Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Clinical Biomarkers Market Share by Application: 2024 VS 2031
 Figure 9. Research and Academic Laboratories Case Studies
 Figure 10. Biopharmaceutical and Biotech Companies Case Studies
 Figure 11. Diagnostic Centers Case Studies
 Figure 12. Others Case Studies
 Figure 13. Clinical Biomarkers Report Years Considered
 Figure 14. Global Clinical Biomarkers Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Clinical Biomarkers Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Clinical Biomarkers Market Share by Region: 2024 VS 2031
 Figure 17. Global Clinical Biomarkers Market Share by Players in 2024
 Figure 18. Global Top Clinical Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Biomarkers as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Clinical Biomarkers Revenue in 2024
 Figure 20. North America Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Clinical Biomarkers Market Share by Country (2020-2031)
 Figure 22. United States Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Clinical Biomarkers Market Share by Country (2020-2031)
 Figure 26. Germany Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Clinical Biomarkers Market Share by Region (2020-2031)
 Figure 34. China Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Clinical Biomarkers Market Share by Country (2020-2031)
 Figure 42. Mexico Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Clinical Biomarkers Market Share by Country (2020-2031)
 Figure 46. Turkey Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Clinical Biomarkers Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Abbott Laboratories Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 50. Agilent Technologies, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 51. ALCEDIAG Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 53. bioMérieux S.A. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 54. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 55. CENTOGENE N.V. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 56. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 57. Enzo Biochem Inc. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 58. Illumina, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 59. Myriad Genetics, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 60. Quest Diagnostics Incorporated Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 61. QIAGEN N.V. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 62. Thermo Fisher Scientific Inc. Revenue Growth Rate in Clinical Biomarkers Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Clinical Biomarker Testing Market Research Report 2024
Global Commercializing Biomarkers Market Research Report 2025
Global Biomarker Market Research Report 2024
Biomarker Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Proteomic Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights Forecast to 2030
Global Biomarker Testing for Cancer Market Research Report 2024
Medical Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biomarker Detection Systems Market Research Report 2024
Global Oncology Biomarker Market Insights Forecast to 2030
Global Diagnostic Biomarker Market Research Report 2024
Global Targeted Biomarker Market Insights Forecast to 2030
Global Brain Biomarker Market Research Report 2024
Global Cancer Biomarkers Detection Market Research Report 2024
Global Chronic Phase Marker Market Research Report 2024
Global Cancer Molecular Biomarkers Market Research Report 2024
Renal Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiac Biomarkers Testing Market Insights Forecast to 2030
Global Cancer Biomarker Market Insights Forecast to 2030
Global Nervous System Markers Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions